Literature DB >> 23403293

The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: a 3 year longitudinal study.

Rosa Ayesa-Arriola1, José Manuel Rodríguez-Sánchez, Rocío Pérez-Iglesias, César González-Blanch, Gema Pardo-García, Rafael Tabares-Seisdedos, Jose L Vázquez-Barquero, Benedicto Crespo-Facorro.   

Abstract

Real-world functional deficits are common and persistent in individuals with psychosis. Cognitive deficits have been shown to compromise functioning. We aimed to study the predictive values of premorbid, sociodemographic, and baseline clinical and neurocognitive factors on long-term functional outcome for individuals with first episode non-affective psychosis. We failed to demonstrate a significant relationship between cognitive deficits at baseline and functional disability at 3 year follow-up. Diagnosis of schizophrenia (OR=2.457, p=0.011), shorter education (OR=1.177, p=0.005) and poor premorbid social adjustment (OR=1.628, p=0.013) emerged as the strongest predictors for the 114 subjects (56%) that exhibited functional disability at 3-year follow-up. A considerable proportion of the variance in functioning (74% at 1 year and 77% at 3 year) remained unexplained by baseline variables. The set of variables that predicted functional outcome at medium- (1 year) and long-term (3 years) differed. In conclusion, the length of follow-up influenced the relationship between baseline variables and functional outcome. A substantial proportion of the variance in function was not explained by these variables and therefore the influence of other factors warrants further investigation. The data support the notion that premorbid social adjustment is an important aspect in functional outcome over the course of the illness.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Early intervention; Neurocognition; Outcome; Schizophrenia

Mesh:

Substances:

Year:  2013        PMID: 23403293     DOI: 10.1016/j.psychres.2013.01.024

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

Review 1.  Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials.

Authors:  Y Iwata; S Nakajima; T Suzuki; R S E Keefe; E Plitman; J K Chung; F Caravaggio; M Mimura; A Graff-Guerrero; H Uchida
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

2.  Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia.

Authors:  Peter E Clayson; Robert S Kern; Keith H Nuechterlein; Barbara J Knowlton; Carrie E Bearden; Tyrone D Cannon; Alan P Fiske; Livon Ghermezi; Jacqueline N Hayata; Gerhard S Hellemann; William P Horan; Kimmy Kee; Junghee Lee; Kenneth L Subotnik; Catherine A Sugar; Joseph Ventura; Cindy M Yee; Michael F Green
Journal:  Schizophr Res       Date:  2018-08-16       Impact factor: 4.939

Review 3.  Common Data Elements for National Institute of Mental Health-Funded Translational Early Psychosis Research.

Authors:  Dost Öngür; Cameron S Carter; Raquel E Gur; Diana Perkins; Akira Sawa; Larry J Seidman; Carol Tamminga; Wayne Huggins; Carol Hamilton
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-06-29

4.  Vulnerability to psychosocial disability in psychosis.

Authors:  S L Griffiths; S J Wood; M Birchwood
Journal:  Epidemiol Psychiatr Sci       Date:  2018-09-12       Impact factor: 6.892

5.  Interdisciplinary approaches to the phenomenology of auditory verbal hallucinations.

Authors:  Angela Woods; Nev Jones; Marco Bernini; Felicity Callard; Ben Alderson-Day; Johanna C Badcock; Vaughan Bell; Chris C H Cook; Thomas Csordas; Clara Humpston; Joel Krueger; Frank Larøi; Simon McCarthy-Jones; Peter Moseley; Hilary Powell; Andrea Raballo; David Smailes; Charles Fernyhough
Journal:  Schizophr Bull       Date:  2014-06-05       Impact factor: 9.306

6.  Continued cannabis use at one year follow up is associated with elevated mood and lower global functioning in bipolar I disorder.

Authors:  Levi Roestad Kvitland; Ingrid Melle; Sofie Ragnhild Aminoff; Christine Demmo; Trine Vik Lagerberg; Ole Andreas Andreassen; Petter Andreas Ringen
Journal:  BMC Psychiatry       Date:  2015-02-05       Impact factor: 3.630

7.  Predicting Symptomatic and Functional Improvements over 1 Year in Patients with First-Episode Psychosis Using Resting-State Electroencephalography.

Authors:  Rinvil Renaldi; Minah Kim; Tak Hyung Lee; Yoo Bin Kwak; Andi J Tanra; Jun Soo Kwon
Journal:  Psychiatry Investig       Date:  2019-08-21       Impact factor: 2.505

8.  Premorbid Social Functioning and Affective Symptoms Predict Subjective Outcome Among Outpatients With Schizophrenia.

Authors:  Christine M Hoertnagl; Alexandra Kaufmann; Nursen Yalcin-Siedentopf; Nicole M Pfaffenberger; Beatrice Frajo-Apor; Silvia Pardeller; Georg Kemmler; Alex Hofer
Journal:  Front Psychiatry       Date:  2020-09-30       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.